Orexo AB (publ) (STO:ORX)
6.09
+0.03 (0.50%)
Oct 15, 2026, 1:17 PM CET
Orexo AB Market Cap
Orexo AB has a market cap or net worth of 225.03 million as of October 14, 2026. It is the 36,207th most valuable company in the world and the 497th biggest in Sweden. Its market cap has decreased by 84.02% in one year.
Market Cap
225.03M
Enterprise Value
-41.97M
Revenue
16.60M
Global Rank
Country Rank
#497 Sweden
PE Ratio
0.49
ChartMarket Cap Chart
Since November 9, 2005, Orexo AB's market cap has decreased from 861.50M to 225.03M, a decrease of -73.88%. That is a compound annual growth rate of -6.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 225.03M | -78.33% |
| Dec 30, 2025 | 1.04B | 72.00% |
| Dec 30, 2024 | 603.84M | 13.47% |
| Dec 29, 2023 | 532.14M | -17.90% |
| Dec 30, 2022 | 648.17M | -45.27% |
| Dec 30, 2021 | 1.18B | -30.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.95B |
| Cereno Scientific AB | 1.12B |
| Dicot Pharma AB | 832.49M |
| EQL Pharma AB | 674.75M |
| Cinclus Pharma Holding AB | 602.20M |
| Moberg Pharma AB | 535.03M |
| Enzymatica AB | 427.21M |
| Klaria Pharma Holding AB (publ.) | 121.14M |